Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:11 AM
Ignite Modification Date:
2025-12-26 @ 11:11 AM
NCT ID:
NCT02109328
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed diagnosis of transitional cell tumors of the bladder or the urothelium.
* Locally advanced (T3b,N0; every T,N+) or metastatic disease.
* Failure of max.2 chemotherapy regimens for metastatic disease (at least 1 including a platinum compound).
* Neoadjuvant/adjuvant therapy considered if relapse occurred within 6 months of the last cycle of chemotherapy.
Exclusion Criteria:
* Failure to meet the eligibility requirements.
* Serious medical or psychiatric illness likely to interfere with participation in this clinical study.
* Major co-morbidities as specified in the protocol.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02109328
Study Brief:
Protocol Section:
NCT02109328